Ambry Genetics Announces Illumina CSPro™ Certification for GA Sequencing

FOR IMMEDIATE RELEASE

Ambry Genetics
15 Argonaut
Aliso Viejo, CA 92656

Aliso Viejo, CA, April 29, 2009 - Ambry Genetics announced today that it has successfully completed Illumina CSPro™ Certification for Genome Analyzer (GA) Sequencing, gaining entry to an elite group of Illumina Certified Service Providers globally. Illumina Inc., a San Diego-based company, provides leading-edge genetic analysis tools to genomics centers worldwide.

The Illumina CSPro™ is the collaborative service provider partnership dedicated to ensuring the delivery of the highest-quality data available for genetic analysis applications. Illumina CSPro™ participants undergo a rigorous two-phase certification process that includes minimum data generation, data certification, and an on-site audit of the facility and processes.

Ambry’s CSO, Anja Kammesheidt said, "the company has been working on the Illumina GA systems since January 2008. We are now offering Illumina CSPro™ Genome Analyzer (GA) Sequencing services to pharma, clinical and academic research groups, while keeping up with Illumina’s technology improvements. We value Illumina’s commitment to innovation and quality, and are excited to now be the second Illumina CSPro™ in the USA for the GA applications"

"Illumina CSPro™ recognizes organizations that provide customers with industry-leading data quality and service in genetic analysis," said Karen Possemato, Illumina's Director of Corporate Marketing. "Ambry Genetics is now a Certified Service Provider able to offer Illumina Genome Analyzer Sequencing services using Illumina technology. Now that Ambry Genetics is a global CSPro™ partner, we are excited to work with them to make it easier for researchers to access the power of Illumina's genetic analysis technologies."


About Ambry Genetics ®

Ambry Genetics is both College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified. Ambry leads in clinical genetic diagnostics and genetics software solutions, combining both to offer the most comprehensive testing menu in the industry. Ambry has established a reputation for sharing data while safeguarding patient privacy, unparalleled service, and responsibly applying new technologies to the clinical molecular diagnostics market. For more information about Ambry Genetics, visit ambrygen.com.

Press Contact:
Aaron Schmidt
Sr Manager, Communications
aschmidt@ambrygen.com
949 457 4679

Search Results

Start your search...